Visa to buy BioCatch for $2.4 billion to expand fraud and cybersecurity capabilities

Visa has agreed to acquire BioCatch, a company known for analyzing digital behavior to flag suspected fraud, in a deal valued at $2.4 billion. The acquisition is designed to broaden Visa’s fraud and cybersecurity offerings as it faces rising risks from account takeovers, phishing, and other attacks that exploit both cards and digital channels.

The transaction, according to the report, would purchase BioCatch from Permira, the investment firm behind the company’s ownership. For Visa, the purchase continues a pattern in which major payments networks seek to bring more advanced risk tooling in-house or under tighter integration, rather than relying solely on third-party partners.

BioCatch’s core premise is behavioral analytics. Instead of looking only at whether a transaction matches a previous pattern, such systems attempt to infer intent by examining how users interact with digital platforms, such as navigation patterns, typing behaviors, and other indicates that can indicate whether a legitimate customer is acting or whether fraudsters are operating accounts.

The price tag of $2.4 billion underscores how much the market values fraud prevention technology, especially tools that can improve detection accuracy without creating excessive false positives. In payments, false alarms can lead to declined transactions and customer friction, so vendors compete on both performance and usability.

Visa has repeatedly framed fraud and security as central to its network, since the company sits in the flow of authorization and settlement for a large volume of card transactions worldwide. Bringing BioCatch into its portfolio could help Visa offer financial institutions additional analytics layers for monitoring risk across mobile, online, and card-based journeys.

From a product standpoint, behavioral fraud detection is particularly relevant to account takeover attempts, where attackers may already have credentials or can trick users into sharing them. By focusing on how activity is performed, behavioral models can be updated and refined as fraud tactics change, a challenge that cybersecurity teams face continuously.

The reported announcement does not, in the information available here, specify deal timing, regulatory review milestones, expected closing conditions, or whether BioCatch’s technology will be marketed as an add-on to existing Visa risk services or integrated more deeply into specific Visa platforms. It also does not disclose revenue contribution, customer concentration, or any forward-looking financial targets tied to the acquisition.

What to watch next is how Visa plans to operationalize the acquisition: whether BioCatch’s technology will be deployed across Visa’s ecosystem through partners and issuers, and what measurable changes Visa expects in fraud prevention. Investors will also look for any further details on integration plans, potential retention of BioCatch’s team, and the timeline for regulatory approvals.